Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155693 | SCV000205403 | uncertain significance | not specified | 2013-05-01 | criteria provided, single submitter | clinical testing | The Ile33041Met variant in TTN has not been reported in individuals with cardiom yopathy or in large population studies. Computational analyses (biochemical amin o acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. At this time, additional information is needed to fully assess the clinical significance of this variant . |
Invitae | RCV001087390 | SCV000555128 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726637 | SCV000701884 | uncertain significance | not provided | 2018-01-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726637 | SCV001815244 | likely benign | not provided | 2019-11-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003965165 | SCV004790552 | likely benign | TTN-related condition | 2023-02-14 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |